[The utilisation of the leukocyte migration inhibition test (L.M.T) in carcinoma of cervix uteri (author's transl)].
The leukocyte migration inhibition test (L.M.T.) was utilized for in vitro studies of cell mediated immunity in gynecologic malignomas. Autogenous peripheral blood leukocytes from 50 patients with a carcinoma of the cervix uteri were studied in about 100 tests. There was found an inhibition of the migration of the autogenous leukocytes in 25 of 47 tests of patients with a CCI without evidence of metastasis or widespread disease. However, the migration of autogenous leukocytes from patients with metastasis or widespread disease (CCII) were only inhibited in 14 of 46 cases. At normal tissue were inhibited in 15 of 89 cases the migration of the autogenous leukocytes.
D000951:Antigens, Neoplasm / Q000276:immunology; D002464:Cell Migration Inhibition; D005260:Female; D006801:Humans; D007962:Leukocytes / Q000276:immunology*; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000276:immunology; D014020:Tissue Extracts / Q000276:immunology; D002583:Uterine Cervical Neoplasms / Q000097:blood / Q000276:immunology*
D000951:Antigens, Neoplasm; D014020:Tissue Extracts
Anwendung des Leukozytenmigrationshemmtestes (LMT) beim Zervixkarzinom.